During the past decade, Prof. Dr. Matei Bals Institute of Infectious Diseases conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prof. Dr. Matei Bals Institute of Infectious Diseases" #1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Prof. Dr. Matei Bals Institute of Infectious Diseases" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "COVID-19" (2 trials), "Influenza" (1 trials) and "Long COVID" (1 trials). Many other conditions were trialed in "Prof. Dr. Matei Bals Institute of Infectious Diseases" in a lesser frequency.

Most popular intervention types in "Prof. Dr. Matei Bals Institute of Infectious Diseases" are "Drug" (6 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ontamalimab" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "Baloxavir Marboxil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prof. Dr. Matei Bals Institute of Infectious Diseases" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Prof. Dr. Matei Bals Institute of Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Prof. Dr. Matei Bals Institute of Infectious Diseases, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Prof. Dr. Matei Bals Institute of Infectious Diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".